Aeon Biopharma reduces shareholder quorum requirement to 33.34%

AEON Biopharma, Inc.

Quorum for shareholder meetings changed from a majority to 33.34% of outstanding voting power.
Amendment to Bylaws adopted on December 18, 2024, effective immediately.
Certificate of Amendment filed as Exhibit 3.1 with the SEC.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

AEON Biopharma, Inc.: Changed quorum requirement for shareholder meetings from a majority to 33.34% of voting power (effective 2024-12-18).

Change: bylaw amendment
Effective: 2024-12-18

Exact text from the filing

On December 18, 2024, Aeon Biopharma, Inc. (the “Company”) amended its amended and restated bylaws (the “Bylaws”) to change the quorum requirement for shareholder meetings from a majority to 33.34% of the voting power of the Company’s outstanding shares entitled to vote at a meeting.

View on SEC.gov

13 governance changes filed in the last 30 days. Browse all governance changes →

AEON Biopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-130805

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.